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Background: Health Related Quality of Life (HRQOL) instruments need disease and country specific validation.
In Arab countries, there is no specific validated questionnaire for assessment of HRQOL in chronic kidney disease
(CKD) patients. The aim of this study was to present an Arabic translation, adaptation, and the subsequent
validation of the kidney disease quality of life-short form (KDQOL-SFTM) version 1.3 questionnaire in a representative
series of Egyptian CKD patients.
Methods: KDQOL-SFTM version 1.3 was translated into Arabic by two independent translators, and then
subsequently translated back into English. After translation disparities were reconciled, the final Arabic questionnaire
was tested by interviewing 100 pre-dialysis CKD (stage 1-4) patients randomly selected from outpatients attending
the Nephrology clinic at the Main Alexandria University Hospital. Test re-test reliability was performed, with a
subsample of 50 consecutive CKD patients, by two interviews 7 days apart and internal consistency estimated by
Cronbach’s α. Discriminant, concept, and construct validity were assessed.
Results: All items of SF-36 met the criterion for internal consistency and were reproducible. Of the 10 kidney
disease targeted scales, only three had Cronbach’s α <0.7: quality of social interaction (0.23), work status (0.28), and
cognitive function (0.60). All disease specific scales were reproducible. Results from discriminant validity showed
that the study questionnaire could discriminate between patients’ subgroups. As for concept validity, the
correlation between all domains of the questionnaire with overall health ratewas significant for all domains except
for the work status, sexual function, emotional wellbeing, and role emotional. Furthermore, the correlation between
the disease specific domains and the two composite summaries of SF-36 (physical and mental composite
summaries) was significant for all domains except for sexual function with mental composite summary. Construct
validity was indicated by the observation that the majority of the domains of the kidney disease targeted scale of
KDQOL-SFTM 1.3 were significantly inter-correlated. Finally, principal component analysis of the kidney disease
targeted scale indicated that this part of the questionnaire could be summarized into 10 factors that together
explained 70.9% of the variance.
Conclusion: The results suggest that this Arabic version of the KDQOL-SFTM 1.3 questionnaire is a valid and reliable
tool for use in Egyptian patients with CKD.
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Chronic kidney disease (CKD) is a worldwide public health
problem. According to the World Health Organization,
diseases of the kidney and urinary tract contribute to the
global burden with approximately 850,000 deaths every
year and more than 115 million disability-adjusted life
years [1]. In Egypt, there is paucity of information about
the incidence and prevalence of the five stages of CKD.
The incidence of end stage renal disease (ESRD) increased
from 65.6 pmp in 1996 to 79.9 in 2001 with gradual rise in
the intervening years, while the prevalence was 225 pmp
in 1996, 314 pmp in 2000, 375 pmp in 2001 and 483 pmp
in 2004. Mortality among dialysis patients increased from
5.4% in 1996 to 6.2% in 2000 [2,3].
The impact of CKD on the patient’s quality of life has
become increasingly recognized as an important out-
come measure as patients’ perception of their well being
and patient-reported outcomes (PROs) are becoming an
integral part of the clinical and social evaluation of
chronic illnesses and are increasingly considered a fun-
damental element for the assessment of the impact of
therapeutic interventions. Measures of Health Related
Quality of Life (HRQOL) have not only become popular
investigative tools, but also have been used in an effort
to define and alter models of health care delivery. The
quality of life of CKD patients is a frequently overlooked
yet critical dimension when evaluating the care of these
patients and may offer unique information for compa-
ring alternative treatment modalities, and for improving
patient satisfaction and clinical outcomes [4].
Evaluation of HRQOL among CKD patients in Egypt
can add new insight in the management of the disease as
it allows the quantification of the disease consequences
according to the patient’s perception and enables adjust-
ment of medical decisions to their physical, emotional,
and social needs. It also improves the adhesion to the
therapeutic plan, the quality of the health care provided,
and patient survival [5].
HRQOL can be assessed using generic instruments,
which allow comparison between patients and general
populations. Questionnaires encompassing both generic
and disease-specific elements represent a valuable
method of assessment which may be applied to specific-
ally explore the impact on QOL of a range of health pro-
blems in CKD patients and test the effect of
interventions in this population [6]. Hays et al., (1994)
[7] developed a 43 disease-specific item tool for indivi-
duals with ESRD undergoing dialysis, together with the
generic Short Form36 (SF36) these items constitute the
Kidney Disease Quality of Life- Short Form (KDQOL-
SFTM) version 1.3 questionnaire. The KDQOL-SFTM 1.3
has been translated into several languages including
Dutch [8], Korean [9], Italian [10], Iranian [11], Brazilian
[12], and Japanese [13] and has been validated forvarious countries. The KDQOL-SF36 questionnaire was
used in Arab countries [14-16].
In the present study the KDQOL-SFTM version 1.3
was modified, translated into Arabic, and culturally
adapted. This Arabic version of the KDQOL-SFTM 1.3
was subsequently tested among a representative sample
of Egyptian pre-dialysis CKD patients to determine the
psychometric properties, reliability, and validity of its
dimensions for use in the assessment of HRQOL among
CKD patients.
Methods
The study protocol was approved by the Ethics Commit-
tee of the Faculty of Medicine, Alexandria University
and followed International Ethical Guidelines for Epi-
demiological Studies [17].
Structure of KDQOL-SFTM version 1.3
The KDQOL-SFTM version 1.3 combines the generic SF-
36 instrument with the kidney disease specific instru-
ment. The questionnaire consists of 80 items divided
into 19 dimensions. The disease specific component of
KDQOL-SFTM 1.3 includes 43 kidney disease targeted
items. They comprise 11 domains, including: symptom/
problem list (12 items), effects of kidney disease (8
items), burden of kidney disease (4 items), cognitive
function (3 items), quality of social interaction (3 items),
sexual function (2 items), sleep (4 items), social support
(2 items), work status (2 items), patient satisfaction (1
item), and dialysis staff encouragement (2 items). SF-36
includes 36 items that measure eight domains of func-
tioning and wellbeing on a 100 point scale. The eight
domains are: physical function (10 items), role limita-
tions caused by physical problems (4 items), role limita-
tions caused by emotional problems (3 items), pain
(2 items), general health perceptions (5 items), social
function (2 items), emotional well-being (5 items), and
energy/fatigue (4 items). The final item, the overall
health rate item, asks the respondents to rate their
health on a 0-10 response scale. Results from the SF-36
instrument are further summarized into a physical com-
posite summary (PCS) score and a mental composite
summary (MCS) score PCS aggregates items from phys-
ical function, role physical, pain, and general health.
MCS aggregates items from role emotional, emotional
wellbeing, energy, and social function [18]. According to
Mapes et al., [19], items of the kidney disease targeted
scale are also summarized into kidney disease composite
summary (KDCS) score on a100 point scale.
The standard scoring program of the KDQOL-SFTM
1.3 is based on the Microsoft Excel 97 spreadsheet pro-
gram and includes information about the computation
method. The scores for each dimension range from 0 to
100, with higher scores reflecting better HRQOL. The
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0-10 overall health rating (question 22) items are scored
as single items [18].
Translation and cultural adaptation
Permission to translate the KDQOL-SFTM version 1.3
questionnaire into the Arabic language was obtained
from its authors. After consulting the KDQOL working
group, minimal modifications were introduced to make
the questionnaire suitable for use among CKD (stage 1-
4) patients. In brief, we excluded the questions about
problems with access site (item 14L for hemodialysis)
and catheter site (item 14M) for peritoneal dialysis, and
about dialysis staff encouragement and support (items
24A and 24B). The question about satisfaction with care
(item 23) was modified by changing "kidney dialysis" to
"kidney disease." These modifications could potentially
alter the psychometric properties of the questionnaire.
Hence, there is a necessity for a new robust validation
study.
The first translation step was accomplished according
to the specifications established by the KDQOL working
group [20]. Forward translation was done independently
by the first author of this paper and by a trained bilin-
gual translator. Both translators rated the difficulty of
translating each item and the associated response
choices using 0 (not at all difficult) to 100 (most diffi-
cult). One bilingual research supervisor and another
Arabic translator compared the two translations and
reconciled the discrepancies. The conceptual equiva-
lency of items and response choices that were rated less
than 75 were re-translated by the original translators
until an acceptable independent rating of equivalence
was obtained. The resulting translation was cognitively
tested among 10 CKD patients. Following the cognitive
testing, the KDQOL-SFTM 1.3 item and response options
were appropriately rewritten. The next step was to con-
vene a panel meeting including two nephrologists, two
nephrology nurses, two CKD patients and the research
coordinator to evaluate the conceptual equivalence of
the translation. The forward translation was then fina-
lized based on the feedback by the panel. The Arabic
version was finally back-translated into U.S. English by
two additional translators following the same metho-
dology described for the first two translators. The back
translators compared their translations and came to an
agreement about discrepancies. The reconciled back
translation was then compared with the original U.S.
English version.
Sampling and field testing
In order to undertake field testing of the Arabic version
of KDQOL-SFTM 1.3 questionnaire (Additional file 1),
100 pre-dialysis CKD patients were randomly selectedfrom patients attending the out-patient Nephrology
clinic, being the pool for all nephrology patients, at the
Main Alexandria University Hospital. The Main Alexan-
dria University Hospital serves patients from different
regions of the country. Patients were interviewed after
their informed consent. Inclusion criteria included
patients aged 18 years and above, diagnosed as pre-
dialysis CKD (stage1-4). Exclusion criteria included
ESRD patients, those on dialysis, had previous renal
transplantation, and those with cognitive impairment.
Test re-test reliability was estimated, with a subsample
of 50 consecutive CKD patients, by two interviews 7
days apart.
Floor and ceiling effects
Ceiling effects were taken as being the percentage of
respondents with scores of 100 and floor effects were
the percentage of respondents having a score of 0. Cei-
ling and floor effects should be less than 20% to ensure
that the scale captures the full range of potential
responses within the population, and that change over
time can be detected [11].
Psychometric evaluation of the questionnaire
Reliability: intra-class correlation coefficient (ICC) was
used for assessment of the test re-test reliability, while
Cronbach’s α coefficient was used to assess the internal
consistency of the questionnaire [21].
Validity: discriminant validity was assessed by compa-
ring between subgroups of the patients based on age,
gender, educational level, working status, history of
hypertension, history of diabetes mellitus, and stage of
CKD. Concept validity was studied by analyzing the cor-
relation coefficients between the scores of the Arabic
version of the KDQOL-SFTM version 1.3 and the overall
health rate scale, and the correlation coefficient between
the kidney disease targeted items and the scores of the
two composite summaries of the SF-36. Construct valid-
ity was examined by comparing the correlation coeffi-
cients between the kidney disease targeted dimensions
[22,23].
Exploratory factor analysis was used to evaluate the
factor structure of the Arabic version of the KDQOL-
SFTM 1.3 questionnaire. Exploratory factor analysis was
performed by the principal component analysis on the
39 items (after modifications) of the kidney targeted
scales (after modifications) to assess the factor structure
of the questionnaire [24].
Statistical analysis
Data was summarized as median and interquartile range
or as percent frequency, where appropriate. The values
for the interpretation of the ICC were: <0.4, weak agree-
ment; 0.4 to 0.75, good agreement; ≥0.75, excellent
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adequate internal consistency reliability was 0.70 or
higher [25].
The validity of the Arabic version of the KDQOL-
SFTM 1.3 was assessed by correlation analysis. Pearson’s
correlation was applied to the normally distributed vari-
ables and Spearman’s rho when criteria of normality
were violated. The Statistical Package for the Social
Sciences (SPSS), version 16.0 for Windows was used for
the analyses. The tests were two-tailed and p < 0.05 was
considered to indicate statistical significance.
Results
Characteristics of the study subjects
As regards the characteristics of the 100 CKD patients
included in the validation of the Arabic version of the
KDQOL-SFTM version 1.3 questionnaire, the median age
of the study sample was 54 (42-60) years. Male patients
constituted 54%. About one third of the CKD patients
(34%) were university graduates and almost one fourth
(24%) were illiterate. Around three fourths of the study
patients (76%) were married, one fourth (25%) were
current smokers, 42% were hypertensive, and 36% were
diabetics. As regards the distribution of the patients by
the stage of CKD, 44% of the patients were in stage 3
CKD while those in stage 4 constituted 56%.
Forward translation
The discrepancy of forward translation between the two
translators was 10%. The 10% discrepancy was resolved
by the two translators by producing versions of non-
concordant parts of the translations until equivalence
was obtained.
Floor effects and ceiling effects
Table 1 shows the distribution of the responses to each
item of the Arabic version of KDQOL-SFTM version 1.3
questionnaire. Among the kidney disease targeted scales,
work status had the highest proportion of both ceiling
and floor effects (18% and 40 %, respectively). This was
followed by the social support item with ceiling and floor
effects of 17% and 6%, respectively. Sexual function also
had a high proportion of floor effect (16%). In the SF-36
scales, role physical had the highest proportion of floor
effect (48%). Role emotional had the highest proportion
of ceiling effect (50%) and a high proportion of floor
effect (24%).
Reliability
Intra-class correlation coefficients of the kidney disease
targeted scales ranged from 0.79 to 0.95 while in the SF-
36 scales ranged from 0.79 to 0.94. ICC coefficient of
both social support in the kidney disease targeted scales
and social function in the SF-36 scales was 0.79. In thekidney disease targeted scales, Cronbach’s α ranged from
0.23 to 0.90. Cronbach’s α for quality of social inter-
action, and work status was 0.23 and 0.28, respectively,
while for cognitive function, it was 0.60. However, for the
rest of kidney disease targeted scales, it was above 0.70.
For the SF-36 scales, Cronbach’s α was 0.70 and above
for all the items (Table 1).
Validation
Discriminant validity
The Arabic version of the KDQOL-SFTM version 1.3
scores were compared between subgroups of the
recruited patients. Table 2 shows that females, those
with history of hypertension, and those with stage 4
CKD have significantly (p < 0.05) lower scores for the
three composite summaries (PCS, MCS, and KDCS
scores). Older and non working patients scored signifi-
cantly (p < 0.05) lower in both PCS and KDCS scores,
while patients with an education less than secondary
school had significantly (p < 0.05) lower scores for MCS
and KDCS scores. Diabetic patients scored significantly
lower for KDCS.
Concept validity
Table 3 presents the correlation between the domains of
the Arabic version of the KDQOL-SF TM 1.3 and the
overall health rate. Overall health rate in the kidney
disease targeted scales was highly correlated with the
effect of kidney disease (p < 0.001), and correlated with
symptoms/problems, burden of kidney disease, cognitive
function, quality of social interaction, sleep, and social
support (p < 0.05). Overall health rate failed to correlate
with work status, sexual function, and patient satisfac-
tion. Among the SF-36 scales; overall health rate corre-
lated with physical function, role-physical, pain, general
health, and social function (p < 0.05). Overall health rate
tended to be correlated with the energy item (p = 0.07)
but failed to correlate with emotional wellbeing and role
emotional items.
Table 4 shows the correlation between the kidney di-
sease targeted scales and the two the main composite
summaries (PCS and MCS) scores. Both PCS and MCS
scores were correlated with all domains of the kidney
disease targeted scales (p < 0.05) with the exception of
MCS score which failed to correlate with the sexual
function.
Construct validity
Most of the domains were highly correlated with corre-
lation coefficient (r) ranging from 0.25 to 0.72 (p <
0.001). Other domains were weakly correlated (r: 0.20 to
0.29, p < 0.05). Some other domains like sexual function
and effects of kidney disease, and social support versus
Table 1 Description and reliability of the Arabic version of KDQOL-SFTM version 1.3 among the 100 CKD patients
Scales Mean ± SD Ceiling % Floor % ICC (n = 50) Cronbach’s α (n = 100)
Kidney disease targeted scales
•Symptoms/problems 77.50 (11.5) 1.0 0.0 0.93 0.81
•Effect of kidney disease 73.84 (13.6) 2.0 0.0 0.88 0.73
•Burden of kidney disease 40.13 (26.6) 0.0 4.0 0.85 0.88
•Work status 49.00 (38.3) 18.0 40.0 0.93 0.28
•Cognitive function 68.73 (13.7) 0.0 0.0 0.93 0.60
•Quality of social interaction 71.40 (10.4) 0.0 0.0 0.92 0.23
•Sexual function 61.50 (23.1) 0.0 16.0 0.95 0.90
•Sleep 58.38 (15.9) 0.0 0.0 0.93 0.90
•Social support 63.17 (28.9) 17.0 6.0 0.79 0.88
•Patient satisfaction 65.67 (17.9) 5.0 0.0 0.94 -
SF- 36
•Physical function 49.10 (27.3) 2.0 5.0 0.93 0.95
•Role physical 28.50 (32.0) 5.0 48.0 0.88 0.76
•Pain 44.65 (23.1) 1.0 5.0 0.94 0.87
•General health 37.50 (19.0) 0.0 0.0 0.92 0.83
•Emotional well being 60.84 (10.0) 0.0 0.0 0.89 0.70
•Role emotional 63.67 (41.9) 50.0 24.0 0.86 0.83
•Social function 54.50 (23.4) 9.0 0.0 0.79 0.88
•Energy/Fatigue 47.80 (14.5) 0.0 0.0 0.94 0.81
•Overall health rate 57.40 (8.6) 0.0 0.0 0.93 0.95
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(Additional file 2).
Exploratory factor analysis
Factor analysis with varimax rotation revealed that the
39 kidney disease specific items encompassed the ten
domains of the kidney targeted scales of the question-
naire after modifications. The Kaiser–Meyer–Olkin
measure of sampling adequacy was 0.73, which is above
the recommended value of 0.60, and the Bartlett’s test of
sphericity was found to be highly significant (Χ2 = 1.830,
p < 0.001). Moreover, all the communalities found to be
above 0.5. Using these previously mentioned indicators,
a factor analysis was conducted on all the 39 items; this
took the form of a principal component analysis. The
initial eigenvalues showed that all 39 items explained
70.9% of the variance in 10 components. Varimax rota-
tion gave higher factor loading as compared to un-
rotated factor method (factor loading ranged from 0.50
to 0.94). Social support, effect of kidney disease, and
burden of kidney disease items exhibited a stronger rela-
tionship (>0.7). Low factor loadings (<0.5) were observed
specially for items” Did you have difficulty concentrating
or thinking?”, “Did you become confused?”, “Awaken
during the night and have trouble falling asleep again?”,
“Have trouble staying awake during the day?”, and“Think about the care you receive for kidney disease, in
terms of your satisfaction, how would you rate the
friendliness and interest shown in you as a person?”
Discussion
This study reports the psychometric characteristics and
the validation of the Arabic version of the KDQOL-SFTM
version 1.3 among pre-dialysis CKD patients. The study
sample was considered representative of CKD patients
in Egypt as both the age and gender distributions of the
patients were closely similar to that found in the 9th
annual report of the Egyptian renal registry [2].
Differences between regions, populations, and cultures
require reliability and validity assessment of measure-
ment instruments [26]. In the Arab countries, this is the
first validation study of the KDQOL-SFTM version 1.3
questionnaire. Other published articles aimed at asses-
sing the HRQOL in CKD patients. Only, one study in
Saudi Arabia merely mentioned that the questionnaire
(KDQOL-SF 36) was validated but there were no details
[14-16].
Although the KDQOL-SFTM version 1.3 questionnaire
was conceived for self administration, we tested the
Arabic version of the KDQOL-SFTM 1.3 by interviewing
100 (stage 1-4) CKD patients. Almost one fourth (24%)
of the study population were illiterate. Administrating
Table 2 Comparison of the Arabic version of KDQOL-SF version 1.3 questionnaire scores for some demographic and
clinical criteria among the 100 CKD patients
Descriptive criteria PCS Mean ± (SD) MCS Mean ± (SD) KDCS Mean ± (SD)
Age
<50 years (35) 38.1 (10.7) 47.9 (6.4) 63.5 (13.5)
≥50 years(65) 29.9 (9.5) 45.2 (9.5) 55.3 (12.0)
P <0.001 0.08 0.003
Gender
Male (54) 35.0 (9.9) 49.2 (7.6) 61.3 (9.4)
Female(46) 32.4 (9.4) 41.2 (6.2) 58.9 (8.5)
P 0.003 0.002 0.004
Education
<Secondary school (49) 32.0 (10.2) 44.6 (7.5) 54.6 (11.8)
≥Secondary school (51) 33.5 (10.7) 47.6 (6.7) 61.6 (13.5)
p 0.5 0.04 0.007
Working status
Not working (43) 29.7 (9.7) 45.2 (7.2) 45.6 (11.5)
Working (57) 35.1 (10.8) 46.8 (7.3) 60.9 (13.7)
p 0.01 0.3 0.02
History of diabetes mellitus
No(64) 33.7 (10.9) 46.3 (7.3) 59.1 (13.9)
Yes (36) 31.0 (10.0) 45.8 (7.5) 54.0 (11.0
p 0.2 0.7 0.04
History of hypertension
No (58) 35.1 (10.0) 42.8 (7.1) 61.1 (10.9)
Yes(42) 32.2 (9.3) 45.8 (7.5) 57.0 (9.2)
p 0.001 0.005 0.01
Stage of CKD
Stage 3 (44) 36.1 (10.2) 48.7 (6.3) 61.7 (9.5)
Stage 4 (56) 32.8 (9.3) 44.8 (7.3) 59.5 (8.7)
p 0.001 0.01 0.02
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for those who could read and write, and as researcher-
administered for those who were illiterate would have
reduced the precision of HRQOL scores due to diffe-
rences in the way of collecting information.
During the forward translation we encountered some
difficulties with terms, for example; describing items that
are not part of everyday life of the Egyptian people. One
of these was “Bowling or playing golf” as these are not
common sports in Egypt. Therefore, It was removed
being an example given, among others, of moderate
activities. Differentiating between “Most of time” and “A
good bit of the time,” and between “Quite a bit” and “Ex-
tremely” posed some difficulty because most of the
Egyptian people regard these responses as representing
similar quantities. By the same token, “Walking more
than one mile”, “Walking several blocks” or “Walking oneblock” are not usual measures of distance in Egypt. To
provide a conceptually equivalent meaning of block or
mile, we estimated the distance in terms of more than
one tram station, one tram station or half a tram station.
Translators also had difficulty in adapting “Several flights
of stairs”, so we expressed it in the form of one floor or
more than one floor.
In the field test, the distribution of responses to spe-
cific items was tested by the ceiling and floor effects.
Although work status had the highest proportion of floor
effect, this effect was smaller in our study than that
reported by other studies [7-9]. This may be due to the
fact that the patients included in the present study were
pre-dialysis CKD patients, while those included in the
other studies were dialysis patients. Also, it may be due
to the younger age of the patients included in our study
than other studies.
Table 3 Correlation between the domains and the overall
health rate of the Arabic version of KDQOL-SF TM version
1.3 among the 100 CKD patients
Scales Overall health rate (r) P
Kidney disease targeted scales
•Symptoms/problems 0.28 0.005
•Effect of kidney disease 0.34 <0.001
•Burden of kidney disease 0.31 0.003
•Work status 0.08 0.44
•Cognitive function 0.21 0.04
•Quality of social interaction 0.29 0.003
•Sexual function 0.19 0.37
•Sleep 0.3 0.002
•Social support 0.23 0.02
•Patient satisfaction 0.16 0.12
SF- 36
•Physical function 0.29 0.004
•Role physical 0.30 0.002
•Pain 0.26 0.009
•General health 0.32 0.001
•Emotional well being -0.017 0.87
•Role emotional 0.14 0.17
•Social function 0.27 0.008
•Energy/Fatigue 0.18 0.07
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scores, which is similar to that reported by Pakpour
et al., [11]. The high mean age of the patients, and the
high proportion of refusal to answer this item due to the
personal/sensitive nature of this question could explain
the difficulties with this item in our Egyptian sample ofTable 4 Correlation between the kidney disease targeted
scales and SF-36 main composite summaries of the
Arabic version of KDQOL-SFTM 1.3 among the 100 CKD
patients
Kidney disease targeted scales PCS, r(p) MCS, r(p)
•Symptoms/problems 0.61 (<0.001) 0.40 (<0.001)
•Effect of kidney disease 0.45 (<0.001) 0.24 (0.02)
•Burden of kidney disease 0.68 (<0.001) 0.53 (<0.001)
•Work status 0.68 (<0.001) 0.37 (<0.001)
•Cognitive functions 0.67 (<0.001) 0.40 (<0.001)
•Quality of social interaction 0.38 (<0.001) 0.55 (<0.001)
•Sexual function 0.45 (<0.001) 0.10 (0.35)
•Sleep 0.61 (<0.001) 0.28 (0.006)
•Social support 0.24 (0.02) 0.24 (0.02)
•Patient satisfaction 0.41 (<0.001) 0.32 (0.001)CKD patients. On the other hand, the ceiling effect was
high in the social support item which is also reported in
the Netherlands study [8]. This may be explained by the
closely knit nature of the Egyptian community.
For the SF-36 part of the questionnaire, role physical
domain reported high floor effect while role emotional
domain reported high ceiling effect. These findings were
similar to those described by Cheung et al., [27].
Thus floor and ceiling effects may reduce the useful-
ness of the above mentioned scales in this Arabic ver-
sion of KDQOL-SFTM 1.3.
Test re-test reliability was assessed in a sufficiently
large subsample (n = 50) of the respondents and scales
were found to be equal or greater than the minimal
required value of 0.40. Therefore, this Arabic version of
the KDQOL-SFTM 1.3 provides reproducible results.
Internal consistency was acceptable for all SF-36 scales
and for most of the kidney disease targeted scales.
Psychometric test results were less consistent for three
dimensions, work status, cognitive function, and quality
of social interaction. For quality of social interaction and
work status, Cronbach’s α was 0.23 and 0.28, respec-
tively. These are low values compared to corresponding
items in validation studies in USA [7], Japan [9], and
Iran [11], but similar to those reported from the
Netherlands [8]. As discussed, a possible explanation for
these low values could be the complexity of the quality
of social interaction item and the high percentage of non
working patients (43%) in our population. Furthermore,
work status consists of a rather limited number of items
with a limited number of response categories, which
could be partly responsible for the low observed results.
Whatever the explanation, scores of these dimensions
should be interpreted with caution in this Arabic
version.
For the remaining seven dimensions of the kidney di-
sease targeted scales and for all the dimensions of SF36,
the internal consistency presented in our study was
more or less similar to that observed in validation stud-
ies in other countries. The good agreement between the
reliability of the scale scores of the original US version
and the Arabic version confirms the measurement
equivalence between them. For most of the dimensions,
only small discrepancies were found, with the exception
of work status and quality of social interaction, which
showed lower values, compared to US reported values
(Table 5). Therefore, apart from these two dimensions,
results of this Arabic version provide acceptable esti-
mates of HRQOL.
Results based on the discriminant validity by subgroup
comparisons showed that the Arabic version of the
KDQOL-SFTM version 1.3 scores could distinguish
between subgroups of the patients based on age, gender,
educational level and also some clinical conditions as
Table 5 Country comparison of internal consistency reliability of the KDQOL-SFTM version 1.3 questionnaire
Scales Egypt US(1) Japan (2) Iran(3) Netherland(4)
Kidney disease targeted scales
•Symptoms/problems 0.81 0.84 0.81 0.92 0.80
•Effects of kidney disease 0.73 0.82 0.79 0.89 0.76
•Burden of kidney disease 0.88 0.83 0.81 0.86 0.80
•Work status 0.28 0.83 0.69 0.71 0.39
•Cognitive function 0.60 0.68 0.73 0.74 0.83
•Quality of social interaction 0.23 0.61 0.35 0.77 0.39
•Sexual function 0.90 0.89 0.92 0.92 0.95
•Sleep 0.90 0.90 0.61 0.77 0.72
•Social support 0.88 0.89 0.76 0.76 0.67
SF-36
•Physical function 0.95 0.92 0.90 0.93 . . ..
•Role-physical 0.76 0.87 0.88 0.89 . . ...
•Pain 0.87 0.90 0.83 0.88 . . ..
•General health 0.83 0.78 0.80 0.74 . . ...
•Mental health 0.70 0.80 0.84 0.73 . . ...
•Role-Emotional 0.83 0.86 0.92 0.79 . . ...
•Social function 0.88 0.87 0.73 0.82 . . ...
•Energy/Fatigue 0.81 0.90 0.81 0.79 . . ...
1 Data by Hays et al (1994).
2 Data by Green et al (2001).
3 Data by Pakpour et al (2011).
4 Data by Korevaar et al (2002).
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of CKD. Our results are in concordance with results
from other studies in which older patients, females,
those with history of comorbidities, and those with
advanced stage of CKD have worse HRQOL [5,28].
Regarding concept validity, all SF-36 scales were
significantly correlated with the overall health rate
(p < 0.05), except for role emotional and emotional
wellbeing domains. Moreover, for the kidney disease-
specific scales, all scales were significantly inter-correlated
(p < 0.05) with the overall health rate except for work status,
sexual function, and patient satisfaction. Also, positive
correlation coefficients were found between all the
dimensions of the Arabic version of the KDQOL-SFTM ver-
sion 1.3 and the two composite summaries of the SF-36.
The correlation coefficients between most of the dimen-
sions of the KDQOL-SFTM 1.3 were moderate to high, indi-
cating that the instrument has an adequate construct
validity.
Exploratory factor analysis of this Arabic version of
the KDQOL-SF version 1.3 revealed that the kidney dis-
ease specific items could be summarized into 10 factors
after the modification and removal of the domain con-
cerned with the dialysis staff encouragement. This is
supported by what was reported by Hays et al., [7].Conclusions
Based on the findings of this study, the Arabic version of
the KDQOL-SFTM version 1.3 is reliable and valid. This
questionnaire could be administered by the health wor-
kers to assess HRQOL among pre-dialysis CKD patients.
Additional files
Additional file 1: The Questionnaire: contains the Arabic version of
the KDQOL-SFTM 1.3 questionnaire that has been validated by the
authors in this study.
Additional file 2: A table: shows correlation between different
items of kidney disease targeted scale of the Arabic version of the
KDQOL-SFTM version 1.3 among the 100 CKD patients.
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